What managers are like....when they DON’T work for Supernuts

Remember this? They got Supernus for 2023 http://www.zydususa.com/Press%20Releases/2017/March_7___Zydus_Announces_Settlement_with_Supernus_on_Trokendi_XR_R___topiramate__Extended_Release_Capsules.pdf

 

Yes we have patent protection until 2023. That protection may be pointless with Qudexy (topiramate ER) going generic with Zydus in March of 2020.

Just wanted to clear any intentional or unintentional confusion by the previous poster.

 

Awesome

 

Thank yiu

 

Oh no! That behavior is unacceptable in pharma! I hope you got his name and demanded to speak to his hiring manager *wink wink*

 

The generic has existed since that company launched the product. Other than how awesome their corporate accounts people are at making deals, I’m not intimidated by this news. I fight and scrap to get any commercial script I can in my state, any Medicaid patient has to step through that product anyways. It would be nice to see our corporate accounts make something happen.

 

The “generic” has always been in name only and is priced about 85% of the brand. It will be a real $4 generic soon so you probably should be at least a little worried scrappy. Agree with the pitiful performance by corporate accounts though it’s embarrassing